ALPHATEC HOLDINGS INC. Logo
US02081G2012
A2AP5V
ATEC

ALPHATEC HOLDINGS INC.

Cargando cotizaciones...

Previsión

El precio objetivo medio de los analistas es de 11,85 € (+83,15 %). La mediana es de 11,39 € (+76,04 %).

Comprar
  17
Mantener
  3
Vender
  1

Debates en la comunidad

Todavía no hay ninguna discusión sobre este activo.

Iniciar debate

  • Alphatec Holdings: CEO makes $1 million insider purchase, revenue and EBITDA significantly increased

    Alphatec Holdings reports Q2 revenue rose 15% to $213.5 million and EBITDA grew 53% to $36 million, driven by 20% more cases performed by surgeons. The company highlights its complete solution for more precise and faster spinal surgeries. Full-year revenue is expected to be $882 million. The CEO personally invested $1 million, putting short positions under pressure. » Más en finanzen.net


  • Alphatec Holdings: CEO purchase triggers short squeeze and stock rises about 20%

    CEO Patrick Miles bought $1.01 million of his own shares near the 52-week low. High short interest led to covering, causing the stock to rise by nearly 20% on September 11, 2026 on increased volume. The company reports 15% revenue growth and positive free cash flow. » Más en finanzen.net


  • Alphatec Holdings: CEO buy near 52-week low sends stock sharply higher

    Alphatec Holdings' stock rose about 19% in afternoon trading after CEO Patrick Miles purchased 115,000 shares worth roughly $1.01 million at a weighted average price of $8.81. The purchase was made near the 52-week low and is seen as a strong insider vote of confidence, which, together with high short interest, contributed to a short squeeze. The company also recently reported a 15% revenue increase to $213.5 million, positive free cash flow, and reaffirmed its full-year guidance of around $882 million, while US markets overall showed a recovery. » Más en de.investing.com


  • Alphatec confirms growth model and full-year targets at Wells Fargo conference

    Alphatec said procedure volume was about 20% higher in the first half and reaffirmed its 2026 forecast of $882 million revenue, $140 million EBITDA and $20 million free cash flow. Management cited increasing surgeon adoption, EOS robotics, software and the Theradaptive acquisition as the main growth drivers, but acknowledged near-term pressure from lower revenue per procedure and reduced follow-up rates for biologics. For 2027 the company is targeting $1 billion in revenue, roughly 18% EBITDA margin and $65 million free cash flow, and sees further upside from margin improvements. Alphatec expects rising surgeon acceptance and product penetration to support long-term growth of 15–20% annually. » Más en de.investing.com


  • Alphatec posts Q1 revenue and surgical volume gains, secures cheaper debt and issues 2026 guidance

    Alphatec reported Q1 2026 total revenue of $192 million, with surgical revenue up 17% and surgical case volume rising 21%; non-GAAP adjusted EBITDA reached $21 million and trailing twelve-month free cash flow was $7 million. The company secured a new bank facility that cuts annual interest expense by over $6 million and extends debt maturities to 2031, ending the quarter with $140 million in cash. For full-year 2026 Alphatec guides total revenue of about $882 million (≈15% growth), surgical revenue near $805 million, adjusted EBITDA around $134 million (15% of revenue) and at least $20 million in free cash flow. » Más en finance.yahoo.com

Datos financieros de la empresa

En el último trimestre, ALPHATEC HOLDINGS INC. tuvo unos ingresos de 195,26 M € y un beneficio neto de -4,83 M €
(EUR) septiembre de 2026
YoY
Ingresos 195,26 M 16,61 %
Beneficio bruto 139,71 M 19,41 %
Beneficio neto -4,83 M 80,17 %
EBITDA 20,85 M 414,89 %

Datos fundamentales

Métrica Valor
Capitalización bursátil
981,19 M €
Número de acciones
155,14 M
Máximo/mínimo de 52 semanas
21,22 € - 6,11 €
Dividendos No
Beta
0,78
Ratio P/E
-12,39
Ratio PEG
-0,18
Ratio P/B
51,27
Ratio P/S
1,28

Perfil de la empresa

Alphatec Holdings, Inc., una empresa de tecnología médica, diseña, desarrolla y perfecciona tecnologías para el tratamiento quirúrgico de trastornos de la columna vertebral. La compañía ofrece SafeOp Neural InformatiX System, una plataforma de productos Alpha InformatiX diseñada para reducir el riesgo de lesiones nerviosas intraoperatorias; el sistema de acceso Sigma transforaminal lumbar interbody fusion basado en pedículos, que proporciona visualización directa de puntos de referencia anatómicos; Sigma PTP Access and Patient Positioning System; el retractor lateral squadron, diseñado para maximizar los resultados en los pacientes; Invictus Spinal Fixation System, un sistema de fijación toracolumbar para tratar una amplia gama de patologías; e Invictus MIS SingleStep System, que permite la colocación mínimamente invasiva de tornillos pediculares. También ofrece Invictus Modular Fixation Systems, diseñados para aumentar la adaptabilidad gracias a la modularidad de los tornillos; el sistema OsseoScrew, para restaurar la integridad de la columna vertebral; Arsenal spinal fixation system, una plataforma integral de fijación toracolumbar para tratar una amplia gama de patologías, desde degenerativas hasta deformidades, y procedimientos quirúrgicos; Aspida Anterior Lumbar Plating System, un sistema de fijación para la fusión intersomática lumbar anterior; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; e Insignia Anterior Cervical Plate System. Además, la compañía ofrece los implantes intersomáticos posteriores IdentiTi Porous Ti, Transcend Lateral y Battalion; y biológicos compuestos por Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix y Amnioshield Amniotic Tissue Barrier, así como productos de imagen EOS. Vende sus productos a través de una red de distribuidores independientes y representantes de ventas directas en Estados Unidos. La compañía fue fundada en 1990 y tiene su sede en Carlsbad, California.

Nombre
ALPHATEC HOLDINGS INC.
CEO
Patrick S. Miles
Sede Carlsbad, ca
Estados Unidos
Sitio web
Sector
Consumo discrecional
Industria
Bienes duraderos del hogar
Salida a bolsa
12/06/2006
Empleados 913

Símbolos bursátiles

Bolsa Símbolo
NASDAQ
ATEC
Frankfurt
L1Z1.F
Düsseldorf
L1Z1.DU
München
L1Z1.MU
🍪

Parqet  usa cookies. Más información